Nisa Investment Advisors
OCEA

Nisa Investment Advisors’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Nisa Investment Advisors’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30
Closed -$117 – 2770
2023
Q3 		$117 Buy
+30
New +$138 ﹤0.01% 2725

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Nisa Investment Advisors's OCEA Position: Q4 2023 in Review

Nisa Investment Advisors sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q4 2023, closing a stake of 30 shares — an estimated $117 sold.

Nisa Investment Advisors first reported a position in OCEA in Q3 2023 and held it in 1 quarter. The position peaked at $117 in Q3 2023. 35 funds tracked by Wall St. Rank hold OCEA as of Q4 2023.

  • Nisa Investment Advisors reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 30 Ocean Biomedical, Inc. Common Stock shares in Q4 2023, an estimated $117.
  • Nisa Investment Advisors first reported a position in Ocean Biomedical, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Nisa Investment Advisors's Ocean Biomedical, Inc. Common Stock position peaked at $117 in Q3 2023.
  • 35 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q4 2023.

Based on Nisa Investment Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.